Dr. Hsin-Cheng Chiu received his Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah in 1994. After serving as a faculty member in the Department of Chemical Engineering at National Chung Tsing University for 15 years, he moved to National Tsing Hua University in 2009. Dr. Chiu has a professional background in design, synthesis and development of stimuli-responsive supramolecular nanoconstructs for targeted delivery and controlled release of therapeutics. His current interests focus on exploiting heterojunction semiconductor nanomedicines for cancer theranostic applications and developing polymeric multifunctional targeted protein degradation chimeras for treatments of cancer and other diseases. He has published more than 100 peer-reviewed research articles, including those in Biomaterials, Journal of Controlled Release, Advanced Functional Materials, Angewandte Chemie, Macromolecules, ACS Nano, etc. Dr. Chiu also served as the President of the Taiwan Biomaterials and Controlled Release Society from 2020 to 2022. His work has been recognized by receiving the Outstanding Research Award from National Science and Technology Council of Taiwan, the Fellow of Biomaterials Science & Engineering from the International Union of Societies of Biomaterials Science & Engineering, the International the Award of Excellence in Research from Li Chio Zen Biomaterial Research Foundation, Academic Excellence Award of National Tsing Hua University, etc.